Antioxidants and K+ channel agonists versus hydrogen therapy during ex vivo lung perfusion

Journal article

Open access

Peer reviewed

European journal of cardio-thoracic surgery, Vol.49(1), pp.357-357

01/2016

PMID: 26012504

Abstract

Antioxidants - therapeutic use

Extracorporeal Circulation - methods

Humans

Hydrogen - therapeutic use

Ischemic Preconditioning - methods

Lung Transplantation

Potassium Channels - agonists

Reperfusion Injury - prevention & control

url

https://doi.org/10.1093/ejcts/ezv192View

Published (Version of record) Open

1 Record Views

Title: Antioxidants and K+ channel agonists versus hydrogen therapy during ex vivo lung perfusion
Creators - without role: Mohamed S A Mohamed - Thoracic Transplantation Department, University Clinic Essen, Essen, Germany mohammed.shehatta1@gmail.com
Publication Details: European journal of cardio-thoracic surgery, Vol.49(1), pp.357-357
Identifiers: 9920522208331
Academic Unit: King Abdulaziz University
Language: English
Resource Type: Journal article